 To demonstrate the comparative safety and efficacy of Cetrotide 3 milligram mg and AntagonTM in the inhibition of a premature luteinizing hormone LH surge in women undergoing ovarian stimulation with recombinant human follicle stimulating hormonehuman menopausal gonadotropin r-hFSHhMG prior to assisted reproductive technology ART and utilizing oral contraceptives pill OCP for cycle programming. 